289 related articles for article (PubMed ID: 34132790)
1. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.
Kinaneh S; Khamaysi I; Karram T; Hamoud S
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34132790
[TBL] [Abstract][Full Text] [Related]
2. The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.
Khezri MR; Varzandeh R; Ghasemnejad-Berenji M
Cell Mol Biol Lett; 2022 Jan; 27(1):6. PubMed ID: 35016612
[TBL] [Abstract][Full Text] [Related]
3. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
4. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic Complications of COVID-19 Infection: A Review.
Castro RA; Frishman WH
Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
[TBL] [Abstract][Full Text] [Related]
6. Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.
Tavassoly O; Safavi F; Tavassoly I
Mol Pharmacol; 2020 Nov; 98(5):612-619. PubMed ID: 32913137
[TBL] [Abstract][Full Text] [Related]
7. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
8. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.
De Pasquale V; Quiccione MS; Tafuri S; Avallone L; Pavone LM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207476
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
Magro G
Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
[No Abstract] [Full Text] [Related]
10. Heparanase-1: From Cancer Biology to a Future Antiviral Target.
Lebsir N; Zoulim F; Grigorov B
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680276
[TBL] [Abstract][Full Text] [Related]
11. Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans.
Bermejo-Jambrina M; Eder J; Kaptein TM; van Hamme JL; Helgers LC; Vlaming KE; Brouwer PJM; van Nuenen AC; Spaargaren M; de Bree GJ; Nijmeijer BM; Kootstra NA; van Gils MJ; Sanders RW; Geijtenbeek TBH
EMBO J; 2021 Oct; 40(20):e106765. PubMed ID: 34510494
[TBL] [Abstract][Full Text] [Related]
12. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
Gando S; Wada T
Front Immunol; 2021; 12():649122. PubMed ID: 34177896
[TBL] [Abstract][Full Text] [Related]
13. Major coagulation disorders and parameters in COVID-19 patients.
Teimury A; Khameneh MT; Khaledi EM
Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
[TBL] [Abstract][Full Text] [Related]
14. Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.
Chhabra M; Wilson JC; Wu L; Davies GJ; Gandhi NS; Ferro V
Chemistry; 2022 Feb; 28(11):e202104222. PubMed ID: 34981584
[TBL] [Abstract][Full Text] [Related]
15. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
[TBL] [Abstract][Full Text] [Related]
16. The
Hu Y; Meng X; Zhang F; Xiang Y; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.
Lang J; Yang N; Deng J; Liu K; Yang P; Zhang G; Jiang C
PLoS One; 2011; 6(8):e23710. PubMed ID: 21887302
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
Amgalan A; Othman M
Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
[TBL] [Abstract][Full Text] [Related]
20. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
Cassinelli G; Zaffaroni N; Lanzi C
Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
